industry
Popular up and coming topics, concerns, and products in the health and wellness industry.
United States Precision Irrigation Market Size & Forecast 2025–2033. AI-Generated.
The United States Precision Irrigation Market is also expected to develop tremendously, growing from US$ 2.15 billion in 2024 to US$ 4.72 billion by 2033, reflecting a CAGR of 9.11% over the forecast period (2025–2033). This strong growth is driven by intensifying water scarcity, climate uncertainty, rising adoption of smart irrigation technologies, and a growing shift toward sustainable farming practices across the nation.
By Renub Research2 months ago in Longevity
United States Rapid Acting Insulin Market Set for Strong Growth Through 2033. AI-Generated.
The United States Rapid Acting Insulin Market is entering a transformative phase, supported by strong clinical demand, rapid technological advancements, and policy reforms aimed at improving insulin affordability. According to Renub Research, the market is expected to rise from US$ 2.32 billion in 2024 to US$ 3.40 billion by 2033, representing a CAGR of 4.33% between 2025 and 2033.
By Renub Research2 months ago in Longevity
United States Cancer Immunotherapy Market Size & Forecast 2025–2033. AI-Generated.
The United States Cancer Immunotherapy Market is accelerating at an extraordinary pace as modern science pushes the boundaries of how the human immune system can be engineered to fight cancer. According to Renub Research, the market is projected to expand from US$ 31.82 Billion in 2024 to US$ 71.65 Billion by 2033, reflecting a powerful CAGR of 9.44% during 2025–2033. This surge is fueled by a combination of increasing cancer prevalence, biomedical innovation, and rapid regulatory approvals that continue to reshape the oncology landscape.
By Janine Root 2 months ago in Longevity
United States Dialysis Market Size & Forecast 2025–2033. AI-Generated.
The United States Dialysis Market is on a strong upward trajectory, expanding from US$ 1.35 billion in 2024 to US$ 1.96 billion by 2033, according to Renub Research. This represents a robust CAGR of 4.25% during 2025–2033, driven by the increasing prevalence of kidney disease, rapid technological improvements in dialysis equipment, and a growing aging population requiring long-term renal care.
By Janine Root 2 months ago in Longevity
United States Multiple Myeloma Market Poised to Reach US$ 12.04 Billion by 2033. AI-Generated.
Introduction The United States Multiple Myeloma Market is entering a transformative growth phase—driven by scientific breakthroughs, expanded clinical research, and rising disease prevalence among aging Americans. According to Renub Research, the market is projected to rise from US$ 6.56 billion in 2024 to US$ 12.04 billion by 2033, representing a robust CAGR of 6.99% during the forecast period (2025–2033). With the nation increasingly prioritizing advanced oncology services and precision medicine, multiple myeloma is becoming a primary focus area for biopharmaceutical innovation.
By Marthan Sir2 months ago in Longevity
United States Vitiligo Market Size and Forecast 2025–2033. AI-Generated.
The United States vitiligo market is entering a transformative era defined by technological innovation, rising awareness, and growing therapeutic demand. According to Renub Research, the United States Vitiligo Market is projected to reach US$ 320.71 million by 2033, rising from US$ 202.87 million in 2024, marking a CAGR of 5.22% between 2025 and 2033. This growth reflects not only improved access to dermatological care but also a deeper societal and medical understanding of vitiligo—a chronic autoimmune condition characterized by the loss of skin pigmentation.
By Marthan Sir2 months ago in Longevity
United States Artificial Sweetener Market Size and Forecast 2025–2033. AI-Generated.
The United States Artificial Sweetener Market is undergoing a powerful transformation driven by shifting consumer priorities, evolving dietary habits, and the increasing emphasis on healthier lifestyles. According to Renub Research, the market is expected to reach US$ 3.25 billion by 2033, rising from US$ 2.10 billion in 2024, growing at a steady CAGR of 5% from 2025 to 2033. As low-calorie, sugar-free, and reduced-sugar products continue to gain acceptance across food, beverage, pharmaceutical, and personal care categories, artificial sweeteners have become essential ingredients in modern American diets.
By jaiklin Fanandish2 months ago in Longevity
United States Precision Medicine Market Size & Forecast 2025–2033. AI-Generated.
The United States Precision Medicine Market is entering a transformative decade, fueled by rapid innovation, supportive government initiatives, and the growing recognition that personalized treatment delivers better outcomes than traditional one-size-fits-all healthcare.
By jaiklin Fanandish2 months ago in Longevity
United States Embolic Protection Device Market Size and Forecast 2025–2033. AI-Generated.
The United States Embolic Protection Device (EPD) Market is poised for solid expansion, projected to reach US$ 650 million by 2033, rising from US$ 360 million in 2024, according to Renub Research. With a CAGR of 6.96% from 2025 to 2033, the market’s advancement is driven by several converging forces—rapid growth in cardiovascular procedures, rising stroke risk in high-risk patients, and relentless innovation in minimally invasive interventions.
By jaiklin Fanandish2 months ago in Longevity
United States Chronic Obstructive Pulmonary Disease Market Size & Forecast 2025–2033. AI-Generated.
The United States Chronic Obstructive Pulmonary Disease (COPD) Market is expanding at a steady pace, driven by rising disease prevalence, an aging population, and advancements in respiratory treatment technologies. According to Renub Research, the U.S. COPD market is projected to rise from US$ 3.97 billion in 2024 to US$ 4.92 billion by 2033, reflecting a CAGR of 2.42% during 2025–2033.
By jaiklin Fanandish2 months ago in Longevity
